KCK MedTech
Overview
KCK MedTech is a venture capital firm that primarily invests in the health tech and med tech sectors . They partner with medical technology companies to improve the standard of care for all . As an evergreen fund, their capital is flexible and long-term oriented .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mainstay Medical | Feb 2024 | Follow-on Offering | - |
| Allotex | Nov 2023 | Series B Extension | Co-investor |
| Candesant Biomedical | Jun 2023 | Series B | Lead |
| Avvio Medical | Oct 2021 | Series B | Co-investor |
| Sonex Health | Sep 2023 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Greg Garfield
Senior Managing Director
Susan Stimson
Managing Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is KCK MedTech based?
Headquarters information for KCK MedTech is not publicly available.
When was KCK MedTech founded?
KCK MedTech was founded in 2015.
How many portfolio companies does KCK MedTech have?
KCK MedTech has 10 portfolio companies in Caplight's dataset.
What are some companies in KCK MedTech's portfolio?
Portfolio companies visible on Caplight include Mainstay Medical, Allotex, Candesant Biomedical, Avvio Medical, Sonex Health.
What was KCK MedTech's most recent investment shown here?
KCK MedTech's most recent investment in this portfolio sample was in Mainstay Medical in 2024.
What sectors does KCK MedTech focus on?
KCK MedTech focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does KCK MedTech focus on?
KCK MedTech typically invests at the MultiStage stage.
What is KCK MedTech's AUM?
KCK MedTech's assets under management are estimated between $100.0M and $250.0M.